Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

PHASE4CompletedINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 7, 2017

Conditions
Kidney TransplantationCytomegalovirus
Interventions
DRUG

Induction therapy with Thymoglobulin, prednisone, everolimus and late introduction of tacrolimus

DRUG

Induction therapy with Thymoglobulin, prednisone, mycophenolate sodium and late introduction of tacrolimus

Trial Locations (1)

04038-002

Hospital do Rim e Hipertensao, São Paulo

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

Sanofi

INDUSTRY

lead

Helio Tedesco Silva Junior

OTHER